These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 11969190)

  • 1. Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides.
    Drake KA; Zhang JH; Harrison RK; McGeehan GM
    Anal Biochem; 2002 May; 304(1):63-9. PubMed ID: 11969190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method to screen ligands of peroxisome proliferator-activated receptor delta.
    Cho MC; Yoon HE; Kang JW; Park SW; Yang Y; Hong JT; Song EY; Paik SG; Kim SH; Yoon DY
    Eur J Pharm Sci; 2006 Dec; 29(5):355-60. PubMed ID: 16930961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
    Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
    Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay.
    Stafslien DK; Vedvik KL; De Rosier T; Ozers MS
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):82-9. PubMed ID: 17184907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
    Gowda K; Marks BD; Zielinski TK; Ozers MS
    Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the mouse peroxisome proliferator-activated receptor delta gene.
    Magge SS; Guardiola-Diaz H
    Biochem Biophys Res Commun; 2002 Jan; 290(1):230-5. PubMed ID: 11779158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation.
    Zhou G; Cummings R; Hermes J; Moller DE
    Methods; 2001 Sep; 25(1):54-61. PubMed ID: 11558997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain.
    Nichols JS; Parks DJ; Consler TG; Blanchard SG
    Anal Biochem; 1998 Mar; 257(2):112-9. PubMed ID: 9514791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor alpha.
    Mukherjee R; Sun S; Santomenna L; Miao B; Walton H; Liao B; Locke K; Zhang JH; Nguyen SH; Zhang LT; Murphy K; Ross HO; Xia MX; Teleha C; Chen SY; Selling B; Wynn R; Burn T; Young PR
    J Steroid Biochem Mol Biol; 2002 Jul; 81(3):217-25. PubMed ID: 12163133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T; Kodama TS; Jingami H; Kamiya N
    Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.
    Wu X; Glickman JF; Bowen BR; Sills MA
    J Biomol Screen; 2003 Aug; 8(4):381-92. PubMed ID: 14567790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors.
    Mettu NB; Stanley TB; Dwyer MA; Jansen MS; Allen JE; Hall JM; McDonnell DP
    Mol Endocrinol; 2007 Oct; 21(10):2361-77. PubMed ID: 17595321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.